Katherine is the co-lead of the Global Health Ethics & Governance Unit at WHO Headquarters, Geneva. Her work focuses on the intersection between ethics, governance and policy making in global health research and practice. Whilst much of her current work is COVID-related, she is also focused on realizing the potential benefits of emerging technologies in different settings; the ethics of clinical trial design, with particular reference to human challenge studies and addressing ethical challenges in scientific research and global health governance.
Prior to joining WHO in 2018, Katherine was the Global Policy Lead at Wellcome, where she provided strategic advice on regulatory, governance and ethical issues. At Wellcome, she led a programme of work focusing on research ethics, global governance and advocacy, epidemic preparedness, genomics and emerging technologies, and evidence into policy. She was involved in many international partnerships and sat on many oversight bodies, including: the PHE Ebola Governance Group; the IDDO Ebola Platform Steering Committee; the H3Africa Ethics and Regulatory Working Group and was the chair of the GLOPID-R data sharing working group.
